CURRICULUM VITAE
HANDAN ÖZEK ERKURAN, MD
1. PERSONAL
INFORMATION
Date of Birth/Hometown: 1982/ Ankara
Sex: Female
Marital Status: Married
Native Language: Turkish
Foreign Language: English (advanced), German
(intermediate)
2.
CURRENT
PROFESSIONAL POSITION
MD,
Consultant Child and Adolescent Psychiatrist (2013-)
University
of Health Sciences, Izmir Dr. Behcet Uz Children’s Research and Training
Hospital, Child and Adolescent Psychiatry Department
3.
EDUCATION/POSTGRADUATE
TRAINING
Ankara University Faculty of Medicine,
1999-2006
Dokuz Eylül University Faculty of
Medicine ; Residency Training in Child and Adolescent Psychiatry
Department, 2007- 2012
4.
PREVIOUS
PROFESSIONAL WORK EXPERIENCE
·
Dokuz Eylül
University Faculty of Medicine ; Residency Training in Child and Adolescent Psychiatry Department (2007-
2012)
·
Balıkesir
Ataturk State Hospital, Child and Adolescent Psychiatry Unit (2012-2013)
·
Izmir Buca
Gyneacology, Obstetrics and Pediatrics Hospital, Child and Adolescent
Psychiatry Unit (2013)
·
Turkish Ministry
of Health Kayseri Research and Training
Hospital, Child and Adolescent Psychiatry Unit (2014)
·
University of
Health Sciences, Izmir Dr. Behcet Uz Children’s Research and Training Hospital,
Child and Adolescent Psychiatry Department (2013-)
5.
TRAINING/COURSES
·
Tavistock
Clinic M-14 Child and Adolescent Psychoanalytic Training and Infamt Observation
Module for Child Psychiatrists, 2007-2018
·
Psychodinamic Concepts in Practice,
Tavistock Clinic Workshop, March 2008
·
Kiddie and Young Adult Schedule for
Affective Disorders and Schizophrenia – Present State and Lifetime (K-SADS P-L)
Turkish Version Course, Hacettepe University Faculty of Medicine Department of
Child Psychiatry, 2008
·
Emotional Availaibility Training
Workshop, Ankara University Faculty of Medicine Department of Child Psychiatry
, Ankara, April 2011
·
Cognitive and Behavioral Therapy
Training for Children and Adolescents, Theoretical and Practice Modules
completed. Therapist/Trainer: Maria Ceu Salvador. 2016-2018, Istanbul/Turkey
6. PUBLICATIONS:
A. International peer-reviewed
publications:
1. Pekcanlar
Akay A, Hiz Kurul S, Özek H,
Cengizhan S, Emiroğlu N, Ellidokuz H. Maternal Reactions to a child with
epilepsy: Depression, anxiety, parental attitudes and family functions.
Epilepsy Research 2011; 95(3): 213-20.
2. Sargin
E, Akay A, Resmi H, Cengizhan S, Özek H,
Ellidokuz H, Miral S, Orcin E. Evaluation of Serum Brain- Derived Neurotrophic
Factor Levels in Children with Attention Deficit Hyperactivity Disorder:
Preliminary Data. Archives of Neuropsychiatry 2012; 49(2): 96-101.
3. Dursun
OB, Guvenir T, Aras S, Ergin C, Mutlu C, Baydur A, Ozbek A, Özek H, Alsen S, İscanli L, Karaman BI,
Goodman R. A new Diagnostic Approach for Turkish speaking Populations: DAWBA
Turkish version. Epidemiology and Psychiatric Sciences 2012; 22(3): 1-8.
4. Alsen
S, Resmi H, Erkuran HÖ, Tufan AE,
Bulbul M, Akay A. Plasma norepinephrine and dopamine levels in prepubertal male
children with Attention Deficit Hyperactivity Disorder do not change with 8
weeks of methylphenidate Treatment. Bulletin of Clinical Psychopharmacology
2015; 25(3):1.
5. Akay
AP, Kaya GC, Baykara B, Demir Y, Erkuran
HÖ, Alsen S, Eren MS, Emiroglu NI, Ertay T, Ozturk Y, Miral S, Durak H,
Tufan AE. Atomoxetine Treatment may decrease striatal dopaminergic transporter
availability after 8 .weeks: Pilot SPECT report of three cases. Neuropsychiatric
Disease and Treatment 2015 Nov 19;11:2909-2912.
6. Akinci
G, Oztura I, Hiz S, Akdogan O, Karaarslan D, Erkuran HÖ, Akay A. Sleep
Structure in Children With Attention-Deficit/Hyperactivity Disorder. Journal of Child Neurology 2015; 30(11): 1520–1525.
7. Sapmaz
ŞY, Sargın E, Ergin C, Erkuran HÖ,
Öztürk M, Aydemir Ö. The Reliability and Validity of Turkish Version of DSM-5
Level 2 Substance Use Disorder Scale. Journal of Dependence 2016;17(3):
116-122.
8. Erkuran HÖ,
Cakaloz B, Onen O, Kutlu A. Suicide attempt with high dose long acting
methylphenidate ingestion: a case presentation. Klinik Psikofarmakoloji
Bülteni-Bulletin of Clinical Psychopharmacology. 2016 Sep 1;26(3):316-8.
9. Yalın
Sapmaz Ş, Ergin D, Şen Celasin N, Erkuran
HÖ, Karaarslan D, Öztekin S, Uzel Tanrıverdi B, Köroğlu E, Aydemir Ö.
Validity and reliability of the Turkish version of the DSM-5 Dissociative
Symptoms Severity Scale–Child Form. Journal of Trauma & Dissociation. 2017
Aug 8;18(4):624-34.
10. Onen
O, Erkuran HÖ. Topiramate in the
Adjunctıve Treatment of Tourette Syndrome: A Case Report. Klinik
Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 2016 Dec
1;26(4):426-8.
11. Sapmaz
SY, Erkuran HÖ, Ergin D, Ozturk M,
Sen Celasin N, Karaarslan D, Koroglu E, Aydemir O. The reliability and validity
of the Turkish Version of the DSM-5 Panic Disorder Severity Scale-Child Form.
JOURNAL OF MOOD DISORDERS. 2017 Jan 1;7(2):110-5.
12. Önen
Ö, Kutlu A, Erkuran HÖ. Treating an
Adolescent with Long QT Syndrome for Bipolar Disorder: A Case Presentation.
Psychopharmacology bulletin. 2017 Jan 26;47(1):33.
13. Kutlu
A, Erkuran HÖ. Okul öncesi yas
grubunda bipolar bozukluk: Üç olgu ve izleme süreçleri/Preschool bipolar
disorder: three cases and their follow-up. Anatolian Journal of Psychiatry 2017
Feb 1;18:15.
14. Sapmaz
SY, Erkuran HÖ, Ergin D, Celasin NS,
Karaarslan D, Ozturk M, Koroglu E, Aydemir O. Validity and Reliability of the
Turkish Version of DSM-5" Severity of Acute Stress Symptoms--Child Age
11-17" Form. Dusunen Adam: Journal of Psychiatry & Neurological Sciences.
2017 Mar 1;30(1).
15. Yalin
Sapmaz S, Erkuran HÖ, Aydemir O.
Validity and reliability of the Turkish version of DSM-5 Level 2 Repetitive
Thoughts and Behaviors Scale-Child Form. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN
JOURNAL OF PSYCHIATRY. 2017 Apr 1;18(2):107-13.
16. Yalin
Sapmaz S, Erkuran HÖ, Kavurma C,
Ozturk M, Uzel Tanriverdi B, Koroglu E, Aydemir O. Validity and reliability of
DSM-5 Level 1 Cross-Cutting Symptom Scale Turkish Version (Child Form for 11-17
Years and Parent Form for 6-17 Years). ANADOLU PSIKIYATRI DERGISI-ANATOLIAN
JOURNAL OF PSYCHIATRY. 2017 Apr 1;18(2):99-106.
17. Yalin
Sapmaz S, Yalin N, Erkuran HÖ,
Oztekin S, Uzel Tanriverdi B, Koroglu E, Aydemir O. Validity and reliability of
the Turkish version of DSM-5 Depression Severity Scale-Child Form. ANADOLU
PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY. 2017 Jun 1;18(3):237-42.
18. Sapmaz
ŞY, Ergin D, Erkuran HÖ, Celasin NŞ,
Öztürk M, Karaarslan D, Köroğlu E, Aydemir Ö. Validity and Reliability of the
Turkish Version of the DSM-5 Posttraumatic Stress Symptom Severity Scale-Child
Form. Archives of Neuropsychiatry. 2017 Sep;54(3):205.
19. Sapmaz
SY, Erkuran HÖ, Ergin D, Ozturk M,
Celasin NS, Karaarslan D, Koroglu E, Aydemir O. Validity and reliability of the
Turkish version of the DSM-5 “Severity Measure for Agoraphobia—Child Age
11–17”. DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES. 2017 Sep
1;30(3):217-23.
20. SAPMAZ
ŞY, ERKURAN HÖ, Yalin N, ÖNEN Ö,
ÖZTEKİN S, Kavurma C, KÖROĞLU E, AYDEMİR Ö. Validity and Reliability of the
Turkish Version for DSM-5 Level 2 Anger Scale (Child Form for Children Aged
11–17 Years and Parent Form for Children Aged 6–17 Years). Archives of
Neuropsychiatry. 2017 Dec;54(4):334.
21. SAPMAZ
ŞY, Ergin D, CELASİN NŞ, Karaarslan D, ÖZTÜRK M, ERKURAN HÖ, KÖROĞLU E, AYDEMİR Ö. Validity and Reliability of the
Turkish version of DSM-5 Social Anxiety Disorder Severity Scale-Child Form.
Archives of Neuropsychiatry. 2017 Dec;54(4):354.
22. Yalın
Sapmaz Ş, Erkuran HÖ, Öztürk M,
Ergin D, Şen Celasin N, Karaarslan D, Köroğlu E, Aydemir Ö. Validity and
reliability of the Turkish version of the DSM-5 Separation Anxiety Disorder
Severity Scale–child form. Psychiatry and Clinical Psychopharmacology. 2017 Dec
12:1-7.
23. Erkuran HÖ,
Aydin Asik E, Yalin Sapmaz S. Diagnostic and treatment process in a 12-year old
adolescent with Kleine-Levin Syndrome: a case presentation. ANADOLU PSIKIYATRI
DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY. 2018 Jan 1;19(1):95-8.
24. Akay
AP, Resmi H, Güney SA, Erkuran HÖ,
Özyurt G, Sargin E, Topuzoglu A, Tufan AE. Serum brain-derived neurotrophic
factor levels in treatment-naïve boys with attention-deficit/hyperactivity
disorder treated with methylphenidate: an 8-week, observational
pretest–posttest study. European child & adolescent psychiatry. 2018 Jan
1;27(1):127-35.
25. Sapmaz
ŞY, Erkuran HÖ, Karaarslan D, Öztürk
M, Ülker GY, Demirgören BS, Köroğlu E, Aydemir Ö. Validity and Reliability of
the Turkish Version of DSM-5 Level 2 Anxiety Scale (Child Form for 11-17 Years
and Parent Form for 6-17 Years). Archives of Neuropsychiatry. 2018;55(2):152.
26. SAPMAZ
ŞY, ERKURAN HÖ, Ergin D, ÖZTÜRK M,
CELASİN NŞ, Karaarslan D, AYDEMİR Ö. Validity and reliability of the Turkish
version of the DSM-5 Generalized Anxiety Disorder Severity Scale for children
aged 11-17 years. Turkish journal of medical sciences. 2018 Feb 23;48(1):74-9.
27. Pekcanlar
Akay A, Eresen Yazıcıoğlu Ç, Alşen Güney S, Erkuran HÖ, Kızıldağ S, Baykara B, Özyurt G, Yıldırımcan Kadıçeşme
Ş, Miral S, İnal Emiroğlu N. Allele frequencies of dopamine D4 receptor gene
(DRD4) and Catechol-O-methyltransferase (COMT) Val158Met polymorphism are
associated with methylphenidate response in adolescents with attention
deficit/hyperactivity disorder: a case control preliminary study. Psychiatry
and Clinical Psychopharmacology. 2018 Apr 3;28(2):177-84.
28. Önen
Ö, Kundak S, Erkuran HÖ, Kutlu A,
Çakaloz B. Quality of life, depression, and anxiety in Turkish children with
vitiligo and their parents. Psychiatry and Clinical Psychopharmacology. 2018
Apr 5:1-0.
29. Akay
AP, Kaya GÇ, Kose S, Yazıcıoğlu ÇE, Erkuran
HÖ, Güney SA, Oğuz K, Keskin D, Baykara B, Emiroğlu Nİ, Eren MŞ. Genetic
imaging study with [Tc-99m] TRODAT-1 SPECT in adolescents with ADHD using
OROS-methylphenidate. Progress in Neuro-Psychopharmacology and Biological
Psychiatry. 2018 Apr 20.
30. Erkuran HÖ,
Sapmaz ŞY, Herdem A, Öztürk M, Bilaç Ö, Önen Ö, Tanriverdi BU, Köroğlu E,
Aydemir Ö. DSM-5 Level 2 Sleep Disorders Scale Validity and Reliability of
Turkish Form (Form for Children Aged 11–17 Years and Parent Form for Children
Aged 6–17 Years). Archives of Neuropsychiatry. 2018 Sep;55(3):256.
31. Sapmaz
SY, Erkuran HÖ, Ergin D, Ozturk M,
Celasin NS, Karaarslan D, Koroglu E, Aydemir O. Validity and Reliability of the
Turkish version of the Severity Measure for Specific Phobia-Child Form
According to DSM-5. DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL
SCIENCES. 2018 Dec 1;31(4):340-6.
32. Yaylacı
F, Erkuran HÖ, Çetin F, Kara H. Neurofeedback
Training in the Treatment of Attention Deficit Hyperactivity Disorder.
Psikiyatride Güncel Yaklaşımlar- Current Approaches in Psychiatry . 2019; 11 (3):1-1.
B.
National
Peer-Reviewed publications:
1. Erkuran HÖ, AKAY A. Prognosis and Predictive Factors for Mood Disorders
in Children and Adolescents. Turkiye Klinikleri Journal of Child
Psychiatry-Special Topics. 2016;2(1):96-100.
2. Önen Ö, Gencer Ö, Erkuran
HÖ, Ekin Lİ. Clinical Features, Coping Styles and Family Functioning in
Relation To Psychiatric Disorders in Childhood Sexual Abuse. Literature
Symposium 2016; 12.
3. Sapmaz
ŞY, Demirgören BS, Öztürk M, Bilaç Ö, Erkuran
HÖ, Köroğlu E, Aydemir Ö. Validity and Reliability of the Turkish Version
of DSM-5 Level 2 Inattention Scale (Parent Form for 6-17 Years). Turkish
Journal of Child and Adolescent Mental Health 2016; 23(3): 227-233.
4. Pilan
BŞ, Bilaç Ö, Orhon Z, Erkuran HÖ. Medication
Use in A Child and Adolescent Inpatient Unit of A Mental Health Hospital. Turkish
Journal of Child and Adolescent Mental Health 2017; 24(3): 207- 218.
7.
International
Presentations and Abstracts:
1. Akay
AP, Kaya GÇ, Baykara HB, Demir Y,
Erkuran HÖ, Alşen S, Eren MŞ, Emiroğlu FN, Ertay T, Öztürk Y. “Tc-99m
TRODAT Brain SPECT changes in patients with attention deficit hyperactivity
disorder in pre- and post- atomoxetine treatment”. 25th ECNP Congress, Vienna,
October 2012 (poster presentation)
2. Akay
AP, Kaya GÇ, Baykara HB, Demir Y,
Erkuran HÖ, Alşen S, Eren MŞ, Emiroğlu FN, Ertay T, Öztürk Y. “Tc-99m
TRODAT Brain SPECT changes in adolescents with attention deficit hyperactivity
disorder after 2 months of methylphenidate therapy”. 25th ECNP Congress, Vienna,
October 2012 (poster presentation)
3. Akay
AP, Resmi H, Erkuran HÖ, Özyurt G,
Bülbül M, Demirgören BS, Beşenek AM. “Plasma Dopamine and Noradrenaline Levels
in Children Diagnosed with Attention Deficit Hyperactivity Disorder: a
Prospective Treatment Study”. 6th International Congress on Psychopharmacology
and International Symposium on Child and Adolescent Psychopharmacology,
Antalya, April 2014 (poster presentation)
4. Akay
AP, Erkuran HÖ, Resmi H, Ellidokuz
H. “Plasma Dopamine and Noradrenaline Levels in Children Diagnosed with
Attention Deficit Hyperactivity Disorder”. 6th International Congress on
Psychopharmacology and International Symposium on Child and Adolescent
Psychopharmacology, Antalya, April 2014 (poster presentation)
5. Sapmaz
ŞY, Ergin D, Celasin NŞ, Öztürk M, Erkuran
HÖ, Karaarslan D, Köroğlu E, Aydemir Ö. “Validity and reliability of the
Turkish version of DSM-5 agoraphobia severity scale-child form”. 8th
International Congress on Psychopharmacology & 4th International Symposium
on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster
presentation)
6. Sapmaz
ŞY, Erkuran HÖ, Ergin D, Celasin NŞ,
Karaarslan D, Öztürk M, Köroğlu E, Aydemir Ö. “Validity and reliability of the
Turkish version of DSM-5 acute stress symptom severity scale-child form”. 8th
International Congress on Psychopharmacology & 4th International Symposium
on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster
presentation)
7. Sapmaz
ŞY, Yalın N, Erkuran HÖ, Öztekin S,
Tanrıverdi BU, Köroğlu E, Aydemir Ö. “Validity and reliability of the Turkish
version of DSM-5 Depression Severity Scale-Child Form”. 8th International
Congress on Psychopharmacology & 4th International Symposium on Child and
Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)
8. Sapmaz
ŞY, Ergin D, Celasin NŞ, Karaarslan D, Öztürk M, Erkuran HÖ, Köroğlu E, Aydemir Ö. “Validity and reliability of the
Turkish version of DSM-5 social anxiety disorder severity scale-child form”. 8th
International Congress on Psychopharmacology & 4th International Symposium
on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster
presentation)
9. Sapmaz
ŞY, Erkuran HÖ, Ergin D, Celasin NŞ,
Karaarslan D, Öztürk M, Köroğlu E, Aydemir Ö. “Validity and reliability of the
Turkish version of DSM-5 specific phobia severity scale-child form”. 8th
International Congress on Psychopharmacology & 4th International Symposium
on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster
presentation)
10. Sapmaz ŞY, Ergin D, Erkuran HÖ, Celasin NŞ, Karaarslan D, Öztürk M, Köroğlu E, Aydemir
Ö. “Validity and reliability of the Turkish version of DSM-5 generalized
anxiety disorder severity scale child form”. 8th International Congress on
Psychopharmacology & 4th International Symposium on Child and Adolescent
Psychopharmacology, Antalya, April 2016 (poster presentation)
11. Sapmaz
ŞY, Ergin D, Celasin NŞ, Erkuran HÖ,
Karaarslan D, Öztekin S, Tanrıverdi BU, Köroğlu E, Aydemir Ö. “Turkish validity
and reliability of DSM-5 dissociative symptoms severity scale-child form”. 8th
International Congress on Psychopharmacology & 4th International Symposium
on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster
presentation)
12. Sapmaz
ŞY, Ergin D, Celasin NŞ, Öztürk M, Erkuran
HÖ, Karaarslan D, Köroğlu E, Aydemir Ö. “Validity and reliability of the
Turkish version of DSM-5 posttraumatic stress symptom severity scale-child form”.
8th International Congress on Psychopharmacology & 4th International
Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016
(poster presentation)
13. Sapmaz
ŞY, Erkuran HÖ, Ergin D, Celasin NŞ,
Karaarslan D, Öztürk M, Köroğlu E, Aydemir Ö. “Validity and reliability of the
Turkish version of DSM-5 acute stress symptom severity scale-child form”. 8th
International Congress on Psychopharmacology & 4th International Symposium
on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster
presentation)
14. Sapmaz
ŞY, Kavurma C, Erkuran HÖ, Öztürk M,
Tanrıverdi BU, Köroğlu E, Aydemir Ö. “Validity and reliability of DSM-5 Level 1
Cross-cutting Symptom Scale Turkish version (Child Form for 11−17 years and
Parent Form for 6−17 years)”. 8th International Congress on Psychopharmacology
& 4th International Symposium on Child and Adolescent Psychopharmacology,
Antalya, April 2016 (poster presentation)
15. Erkuran HÖ,
Sapmaz ŞY, Herdem A, Öztürk M, Bilaç Ö, Önen Ö, Tanrıverdi BU, Köroğlu E,
Aydemir Ö. “DSM-5 level 2 sleep disorders scale Turkish validity and
reliability study”. 8th International Congress on Psychopharmacology & 4th
International Symposium on Child and Adolescent Psychopharmacology, Antalya,
April 2016 (poster presentation)
16. Sapmaz
ŞY, Demirgören BS, Öztürk M, Bilaç Ö, Erkuran
HÖ, Köroğlu E, Aydemir Ö. “The Reliability and Validity of the Turkish
Version of DSM-5 Level 2 Inattention Scale (Parent Form for 6-17 Years)”. 9th
International Congress on Psychopharmacology & 5th International Symposium
on Child and Adolescent Psychopharmacology, Antalya, April 2017 (oral
presentation)
17. Önen
Ö, Kutlu A, Erkuran HÖ. “Dıagnosıng
An 11-Year Old Gırl Wıth Narcolepsy In A Chıld Psychıatry Unıt: A Case
Presentatıon”. 9th International Congress on Psychopharmacology & 5th
International Symposium on Child and Adolescent Psychopharmacology, Antalya,
April 2017 (poster presentation)
18. Yaylacı
F, Erkuran HÖ, Eyüboğlu M. “Early-term
Aripiprazole Augmentation and Clinical Efficacy: A Case Series of Six
Adolescents”. 9th International Congress on Psychopharmacology & 5th
International Symposium on Child and Adolescent Psychopharmacology, Antalya,
April 2017 (poster presentation)
19. Erkuran HÖ,
Aşık EA, Sapmaz ŞY. “Dıagnostıc And Treatment Process In A 12-Year Old
Adolescent Wıth Kleıne-Levın Syndrome: A Case Presentatıon”. 9th International
Congress on Psychopharmacology & 5th International Symposium on Child and
Adolescent Psychopharmacology, Antalya, April 2017 (poster presentation)
20. Yaylacı
F, Erkuran HÖ. “Acute Dystonic
Reaction Induced by Low-Dose Aripiprazole In an Adolescent Case”. 9th
International Congress on Psychopharmacology & 5th International Symposium
on Child and Adolescent Psychopharmacology, Antalya, April 2017 (poster
presentation)
21. Sapmaz
ŞY, Erkuran HÖ, Ergin D, Celasin NŞ,
Öztürk M, Karaarslan D, Köroğlu E, Aydemir Ö. “Valıdıty And Relıabılıty Of The
Turkısh Versıon Of Dsm-5 Separatıon Anxıety Dısorder Severıty Scale- Chıld Form”.
17th International Congress of European Society for Child and Adolescent
Psychiatry (ESCAP), Geneva, July 2017 (poster presentation)
22. Sapmaz
ŞY, Demirgören BS, Öztürk M, Bilaç Ö, Erkuran
HÖ, Köroğlu E, Aydemir Ö. “Validity and Reliability of the Turkish Version
of DSM-5 Level 2 Inattention Scale (Parent Form for 6-17 Years)”. 17th
International Congress of European Society for Child and Adolescent Psychiatry
(ESCAP), Geneva, July 2017 (poster presentation)
23. Kutlu
A, Erkuran HÖ. “Preschool Bipolar
Disorder: Three Cases and Their Follow- Up”. 17th International Congress of
European Society for Child and Adolescent Psychiatry (ESCAP), Geneva, July 2017
(poster presentation)
24. Küçük
Ö, Yaylacı F, Erkuran HÖ. “Oropharyngeal
dysphagia induced by zuclopenthixol acetate”. 10th International Congress on
Psychopharmacology & 6th International Symposium on Child and Adolescent
Psychopharmacology, Antalya, April 2018 (poster presentation)
25. Yaylacı
F, Küçük Ö, Erkuran HÖ. “L-carnitine
use as a triggering factor for the onset of Kleine- Levin syndrome: a case
presentation”. 10th International Congress on Psychopharmacology & 6th
International Symposium on Child and Adolescent Psychopharmacology, April 2018
(poster presentation)
26. Erkuran
HÖ, Küçük Ö, Yaylacı F, Şahbudak B. “OCD in the context of separation and
Individualization: a case presentation”. 23rd World Congress of the
International Association for Child and Adolescent Psychiatry and Allied
Professions (IACAPAP), Prague, July 2018 (poster presentation)
27. Erkuran HÖ, Yaylacı
F, Küçük Ö, Şahbudak B. “Terrified of menstruating: a case of anorexia”. 23rd
World Congress of the International Association for Child and Adolescent
Psychiatry and Allied Professions (IACAPAP), Prague, July 2018 (poster
presentation)
28. Erkuran HÖ, Binici
NC, Önen Ö, Kutlu A, Balım A, Çakaloz B. “Evaluation of disability reports in a
children’s hospital: Data of a 1-year retrospective chart review”. 23rd World
Congress of the International Association for Child and Adolescent Psychiatry
and Allied Professions (IACAPAP), Prague, July 2018 (oral presentation-
research symposium)
8.
National
Presentations and Abstracts:
1.
Önen Ö, Özek H, İşcanlı L, Gencer Ö. “Cinsel
istismara uğrayan ergenlerde bireysel, ailesel ve istismara ait özelliklerin
tanımlanarak istismara uğrama ve psikiyatrik bozukluk oluşumu üzerine
etkilerinin araştırılması: Kontrollü bir çalışma”. 19. Ulusal Çocuk ve Ergen Ruh
Sağlığı ve Hastalıkları Kongresi, Antakya, Nisan 2009 (poster presentation)
2.
Özek
H,
Akay AP, Alşen S, Kurul SH, Emiroğlu FN, Ellidokuz H. “Epilepsi Tanısı olan
Çocukların Annelerinin Tepkileri: Anksiyete, Depresyon, Tutum ve Aile
İşlevleri”. 20. Ulusal Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi,
Bodrum, Nisan 2010 ( oral presentation)
3. Dursun
OB, Güvenir T, Aras Ş, Ergin C, Mutlu C, Özbek A, Özek H, Alşen S, İşcanlı L, Karaman Bİ, Goodman R. “Yeni bir
tanılama aracı; Gelişim ve Ruhsal Sağlık Değerlendirmesi tanı paketinin Türkçe
geçerlik ve güvenirlik çalışması. 21. Ulusal Çocuk ve Ergen Ruh Sağlığı ve
Hastalıkları Kongresi,Antalya, Nisan 2011 (poster presentation)
4. Akıncı
G, Öztura I, Kurul SH, Akdoğan O, Akay AP, Özek
H. “Dikkat Eksikliğive Hiperaktivite Bozukluğu olan Çocuklarda Uyku
Bozukluklarının Değerlendirilmesi”. 13. Ulusal Çocuk Nörolojisi Kongresi,
Kapadokya, Mayıs 2011 (poster presentation)
5. Akay
AP, Kaya GÇ, Baykara B, Demir Y, Eren MŞ, Erkuran
HÖ, Emiroğlu N, Ertay T, Öztürk Y, Miral S. 24. Ulusal Nükleer Tıp
Kongresi, Antalya, Nisan 2012 (poster bildiri)
6.
Erkuran
HÖ. “Internet
Bağımlılığı Nörobiyolojisi ve Eşlik Eden Psikiyatrik Durumlar”. 9. Ulusal Alkol
ve Madde Bağımlılığı Kongresi, Edirne, Aralık 2015 (oral presentation)
7.
Sapmaz ŞY, Erkuran HÖ, Yalın N, Önen Ö, Öztekin S,
Kavurma C, Köroğlu E, Aydemir Ö. “DSM-5 Düzey 2 Öfke Ölçeği Türkçe Formu’nun
Güvenirliği ve Geçerliği (11-17 yaş çocuk formu ve 6-17 yaş ebeveyn formu)”.
26. Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, İzmir, Nisan 2016
(oral presentation)
8.
Sapmaz ŞY, Ergin
D, Erkuran HÖ, Celasin NŞ,Karaarslan D, Öztürk M, Köroğlu E,
Aydemir Ö. “DSM-V Panik Bozukluk Şiddeti Ölçeği Çocuk Formu’nun Türkçe
Güvenirlik ve Geçerliği”. 26. Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi,
İzmir, Nisan 2016 (oral presentation)
9.
Sapmaz ŞY, Erkuran HÖ, Karaaslan D, Öztürk M,
Ülker GY, Demirgören BS, Köroğlu E, Aydemir Ö. “DSM-5 Düzey 2 Anksiyete Ölçeği
Türkçe Formunun Güvenilirliği ve Geçerliliği (11-17 yaş çocuk ve 6-17 yaş
ebeveyn formları)”. 26. Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi,
İzmir, Nisan 2016 (poster presentation)
10. Sapmaz
ŞY, Ergin D, Erkuran HÖ, Celasin NŞ,
Karaarslan D, Öztürk M, Köroğlu E, Aydemir Ö. “DSM-5 Panik Bozukluk Şiddet
Ölçeği Çocuk Formu'nun Türkçe Güvenilirliği ve Geçerliliği”. 26. Çocuk ve Ergen
Ruh Sağlığı ve Hastalıkları Kongresi, İzmir, Nisan 2016 (poster presentation)
11. Sapmaz
ŞY, Erkuran HÖ, Öztekin S,
Tanrıverdi BU, Kavurma C, Köroğlu E, Aydemir Ö. “DSM-5 Düzey 2 Yineleyici
Düşünceler ve Davranışlar Ölçeği Çocuk Formunun Türkçe Güvenilirliği ve
Geçerliliği”. 26. Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, İzmir,
Nisan 2016 (poster presentation)
12. Sapmaz
ŞY, Erkuran HÖ, Kavurma C, Öztürk M,
Tanrıverdi BU, Köroğlu E, Aydemir Ö. “DSM-V Düzey 1 Kesitsel Belirti Tarama
Ölçeği Türkçe Formu’nun Geçerliği ve Güvenirliği (11-17 Yaş Çocuk Formu ve 6-17
yaş Ebeveyn Formu)”. 15. Ulusal Aile Hekimliği Kongresi, Ankara, Ekim 2016
(oral presentation)
13. Önen
Ö, Kundak S, Erkuran HÖ, Kutlu A,
Çakaloz B. “Vitiligo Hastalığı olan Çocuklar ve Ebeveynlerinin Yaşam Kalitesi,
Depresyon ve Kaygı Düzeyleri”. 5. Ulusal Sağlıkta Yaşam Kalitesi Kongresi,
İzmir, Kasım 2016 (oral presentation)
14. Sapmaz
ŞY, Erkuran HÖ, Ergin D, Celasin NŞ,
Öztürk M, Karaarslan D, Köroğlu E, Aydemir Ö. “DSM-5 Ayrılık Anksiyetesi
Bozukluğu Şiddet Ölçeği Çocuk Formu’nun (11-17 yaş) Türkçe Güvenirlik ve
Geçerliği”. 21. Ergen Günleri, Denizli, Aralık 2016 (oral presentation)
15. Önen
Ö, Kutlu A, Erkuran HÖ. “Long QT
Sendromu Tanılı Ergen Bipolar Olguda Tedavi: Bir Olgu Sunumu”. 21. Ergen
Günleri, Denizli, Aralık 2016 (oral presentation)
16. Erkuran HÖ.
“Bebek ve Küçük Çocuklarda Beslenme Bozuklukları”. Dr Behçet Uz Kış Okulu,
İzmir, Aralık 2016 (speaker)
17. Erkuran HÖ, Sapmaz
ŞY, Ünlü GE, Çakaloz B, Kutlu A, Önen Ö. “Çocuk ve Ergenlerde Atipik
Antipsikotik Kullanımı, Metabolik Sendrom ve İlişkili Etmenler”. 3. Selahattin
Şenol Bahar Okulu, Bodrum, Mart 2017 (oral presentation)
18. Erkuran HÖ. “Otistik
Spektrum Bozukluklarında Davranış Sorunları ve Baş Etme Yöntemleri”. İzmir Halk
Sağlığı Müdürlüğü, Mart 2017 (speaker)
19. Akıncı
G, Eraslan C, Demir M, Erkuran HÖ, Gürbüz G, Özyılmaz B, Edizer S, Yılmaz S,
Ünalp A. “Korpus kallozum anormalliklerinde nöroradyolojik sınıflamanın klinik,
nöropsikiatrik, ve genetik özellikler ile ilişkisi”. 19. Ulusal Çocuk Nöroloji
Kongresi, Antalya, Nisan 2017 (poster presentation)
20. Akay
AP, Güney SA, Erkuran HÖ, Gönül AS,
Baykara B, Emiroğlu Nİ, Eren MŞ, Keskin D, Erkaya T, Kaya GÇ, Demir Y, Miral S,
Durak H. “An Imaging Discontinuation Study of Adolescents with ADHD using OROS-
Methylphenidate: Assessing with [Tc-99m] TRODAT-1 SPECT”. 27th Turkish Child
and Adolescent Psychiatry Congress, Çeşme, Mayıs 2017 (oral presentation)
21. Akay
AP, Yazıcıoğlu ÇE, Erkuran HÖ, Güney
SA, Gönül AS, Baykara B, Emiroğlu N, Demir Y, Eren MŞ, Kızıldağ S, Gökçelli DK,
Ertay T, Özsoylu D, Miral S, Durak H, Kaya GÇ. “A Genetic Imaging Study of
Adolescents with Attention-deficit/Hyperavtivity Disorder using
OROS-Methylphenidate: Assessing the Dopamine Transporter Gene with [Tc-99m]
TRODAT-1 SPECT”. 27th Turkish Child and Adolescent Psychiatry Congress, Çeşme,
Mayıs 2017 (poster presentation)
22. Erkuran HÖ.
“Çocuk Ruh Sağlığı Sınır İhlali Komisyonu”. 27. Ulusal Çocuk ve Ergen Ruh
Sağlığı ve Hastalıkları Kongresi, Çeşme, Mayıs 2017 (speaker)
23. Erkuran HÖ.
“Anksiyete Bozuklukları, Travma ve Stresle İlişkili Bozukluklar ve
İnflamasyon”. 27. Ulusal Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi,
Çeşme, Mayıs 2017 (oral presentation)
24. Sapmaz
ŞY, Erkuran HÖ, Tanrıverdi BU, Öztürk
M, Köroğlu E, Aydemir Ö. “DSM-5 Kişilik Envanteri Çocuk Formunun Türkçe
Güvenilirliği ve Geçerliliği”. 22. Ulusal Ergen Günleri, İstanbul, Aralık 2017
(poster presentation)
25. Erkuran HÖ.
“Çocuk Psikiyatrisi ve Diyet”. 28. Ulusal Çocuk ve Ergen Ruh Sağlığı ve
Hastalıkları Kongresi, İstanbul, Mayıs 2018 (speaker)
26. Erkuran HÖ.
“Dikkat Eksikliği ve Hiperaktivite Bozukluğu’nda Neurofeedback ve Alternatif
Tedavilerin Yeri”. 54. Ulusal Psikiyatri Kongresi, İzmir, Ekim 2018 (speaker)
27. Yaylacı
F, Küçük Ö, Erkuran HÖ, Şahbudak B.
“Effects of Shadow Teacher Intervention on Emotional and Behavioral
Characteristics, Bullying and the Overall Life Quality of the Family of a Case
Diagnosed with Autistic Spectrum Disorder who was Bullied at School”. 28. Çocuk
ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, İstanbul, Mayıs 2018 (oral
presentation)
9.
Internationally/Nationally
Published Books/Book Chapters
1.
Sapmaz ŞY, Erkuran HÖ (2016). Çocuklarda ve Ergenlerde Uyku Bozuklukları. Erhan Akıncı, Fatma
Özlem Orhan ve Mehmet Murat Demet (Ed.), Uyku Bozuklukları Tanı ve Tedavi
Kitabı (s. 305-315) içinde. Yer: Türk Psikiyatri Derneği, Ankara.
2.
Erkuran
HÖ,
Akay AP (2017). Karın Ağrısı/Bedensel
Belirti Bozukluğu. Salih Kavukçu (Ed.), Olgu Örnekleri ile Tanıdan Tedaviye
Çocuk Hastalıkları (1.bs, ISBN: 978-605-9415-29-3) içinde. Yakın Doğu
Üniversitesi Yayınevi.
10. Medical
dissertation thesis: Evaluation of Plasma Dopamine and
Noradrenaline Levels in Children Diagnosed with Attention Deficit Hyperactivity
Disorder (2012, Dokuz Eylul
University, School of Medicine, Child and Adolescent Psychiatry Department, Izmir).
Supervisor: Prof. Dr.
Aynur AKAY
11. Citations:
75 (updated in February 2019)
1. Maternal
reactions to a child with epilepsy: depression, anxiety, parental attitudes and
family functions
i.
39
citations
2. Sleep
structure in children with Attention- Deficit/Hyperactivity Disorder
i.
16
citations
3. Evaluation
of serum brain-derived neurotrophic factor levels in children with Attention
Deficit Hyperactivity Disorder: preliminary Data
i.
6
citations
4. A
new Diagnostic Approach for Turkish speaking populations DAWBA Turkish Version
i.
4
citations
5. Topiramate
in the Adjunctive Treatment of Tourette Syndrome: A Case Report
i.
2
citations
6. Cinsel
istismara uğrayan ergen olgularda bireysel, ailesel ve istismara ait
özelliklerin tanımlanması ve bu özellikler ile birlikte başa çıkma biçimleri,
aile işlevleri ve anne- baba tutumlarının ve olgu olmaya etkisinin belirlenmesi
i.
2
citations
7. Allele
frequencies of dopamine D4 receptor gene (DRD4) and
Catechol-O-methyltransferase (COMT) Val158Met polymorphism are associated with
methylphenidate response in adolescents with Attention Deficit/Hyperactivity
Disorder: a case/control preliminary study
i.
1 citation
8. Serum
brain-derived neurotrophic factor levels in treatment- naive boys with
Attention Deficit Hyperactivity Disorder treated with methylphenidate: an
8-week, observational pretest-posttest study
i.
1
citation
9. Validity
and Reliability of the Turkish Version for DSM-5 Level 2 Anger Scale (Child
Form for Children Aged 11-17 Years and Parent Form for Children Aged 6-17
Years)
i.
1 citation
10. Preschool
bipolar disorder: three cases and their follow-up
i.
1
citation
11. Suicide
attempt with high dose long acting methylphenidate ingestion: a case
presentation
i.
1
citation
12. Plasma
Norepinephrine and Dopamine Levels in Prepubertal Male Children with Attention
Deficit- Hyperactivity Disorder do not change with 8 weeks of methylphenidate
treatment
i.
1
citation
12. Memberships
to Professional association and foundations:
1.
Turkish Medical
Association
2.
Psychiatric
Association of Turkey
3.
Turkish
Association for Child and Adolescent Psychiatry
4.
Turkish
Association of Cognitive and Behavioral Therapies
13. Awards:
Prof. Dr. Atilla Turgay Poster Presentation Award,
1st Place. 27th Turkish Child and
Adolescent Psychiatry Congress, May 2017, Çeşme/Turkey.